financetom
EOLS
financetom
/
Healthcare
/
EOLS
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Evolus, Inc.EOLS
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
584.68M
Revenue (ttm)
266.27M
Net Income (ttm)
-50.42M
Shares Out
63.59M
EPS (ttm)
-0.81
PE Ratio
n/a
Forward PE
n/a
Dividend
n/a
Ex-Dividend Date
n/a
Volume
349,759
Open
9.45
Previous Close
9.42
Day's Range
9.06 - 9.67
52-Week Range
8.67 - 17.82
Beta
0.97
Analysts
Strong Buy
Price Target
24.67 (+168.3%)
Earnings Date
May 6, 2025
Description >

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States.

The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults.

It serves self-pay aesthetic healthcare market. Evolus, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.

Copyright 2023-2025 - www.financetom.com All Rights Reserved